HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Oncologist
; 25(10): 886-893, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32353192
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biliary Tract Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
Italy